EyePoint Pharmaceuticals' Q1 Cash And Investments On March 31, 2024 Of $299M Is Expected To Provide Cash Runway Into 2026
EyePoint Pharmaceuticals' Q1 Cash And Investments On March 31, 2024 Of $299M Is Expected To Provide Cash Runway Into 2026
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.